Future Horizons in the Global CMV Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country
Upcoming SlideShare
Loading in...5
×

Like this? Share it with your network

Share

Future Horizons in the Global CMV Diagnostic Market: US, Europe, Japan Test Volume, Sales Forecasts and Supplier Shares by Country

  • 234 views
Uploaded on

 

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
234
On Slideshare
234
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. Future Horizons in the Global CMV Diagnostic Market: US,Europe, Japan Test Volume, Sales Forecasts and Supplier Sharesby CountryReport Details:Published:August 2012No. of Pages: 231Price: Single User License – US$4850The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US,Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMVdefinition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year testvolume and sales forecasts by country for the following market segments: HospitalsCommercial/Private Labs Blood Banks Physician Offices Public Health Labs For each country, inaddition to test volume and sales projections, the report presents sales and market shareestimates for major suppliers of CMV tests.Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies,Immunoassays, IT and other technologies; reviews features and operating characteristics ofautomated analyzers; profiles leading suppliers and recent market entrants developing innovativetechnologies and products; and identifies emerging business expansion opportunities, alternativemarket penetration strategies, market entry barriers and risks, and strategic planning issues andconcerns.Get your copy of this report @http://www.reportsnreports.com/reports/190495-future-horizons-in-the-global-cmv-diagnostic-market-us-europe-japan-test-volume-sales-forecasts-and-supplier-shares-by-country.htmlMajor points covered in Table of Contents of this report includeTable of ContentsI. IntroductionII. CMV Worldwide Market and Technology OverviewA. BackgroundB. Diagnostic TestsC. Vaccines and DrugsD. Instrumentation Review of Leading Analyzers Marketedby Abbott, Beckman Coulter/Danaher, BioMerieux,
  • 2. Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh,Wallac and Other SuppliersE. Emerging Diagnostic Technologies1. Molecular Diagnostics2. Monoclonal Antibodies3. Immunoassays4. Differential Light Scattering5. Information Technology6. Artificial Intelligence7. Liposomes8. Flow Cytometry9. Chromatography10. Diagnostic Imaging11. Gel Microdroplets12. OtherIII. France: Market Size, Growth and Major Suppliers’ Sales and Market SharesIV. Germany: Market Size, Growth and Major Suppliers’ Sales and Market SharesV. Italy: Market Size, Growth and Major Suppliers’ Sales and Market SharesVI. Japan: Market Size, Growth and Major Suppliers’ Sales and Market SharesVII. Spain: Market Size, Growth and Major Suppliers’ Sales and Market SharesVIII. UK: Market Size, Growth and Major Suppliers’ Sales and Market SharesIX. USA: Market Size, Growth and Major Suppliers’ Sales and Market SharesX. Alternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies for DecentralizedTesting Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types of Distributors7. Market SegmentationXI. Potential Market Entry Barriers and RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge and LimitationsE. Patent ProtectionF. Regulatory Constraints
  • 3. G. Decentralized Testing Market ChallengesXII. Competitive AssessmentsAbbottAffymetrixBeckman Coulter/DanaherBecton DickinsonbioMerieuxBio-RadCepheidDiamedixDiaSorinEiken ChemicalEnzo BiochemFujirebioGen-ProbeHologicID BiomedicalInnogenetics/SolvayKreatechLife TechnologyLonzaNanogen/ElitechNovartis DiagnosticsOrtho-Clinical DiagnosticsQiagenRocheScienionSequenomSeraCareSiemensTakara BioThermo FisherWallacWakoList of TablesMajor Companies Developing or Marketing CMV TestsFranceCMV Test Volume and Diagnostics Sales Forecastby Market SegmentFranceCMV Testing Market Diagnostics Salesby Major Supplier
  • 4. GermanyCMV Test Volume and Diagnostics Sales Forecastby Market SegmentGermanyCMV Testing Market Diagnostics Salesby Major SupplierItalyCMV Test Volume and Diagnostics Sales Forecastby Market SegmentItalyCMV Testing Market Diagnostics Salesby Major SupplierJapanCMV Test Volume and Diagnostics Sales Forecastby Market SegmentJapanCMV Testing Market Diagnostics Salesby Major SupplierSpainCMV Test Volume and Diagnostics Sales Forecastby Market SegmentSpainCMV Testing Market Diagnostics Salesby Major SupplierU.K.CMV Test Volume and Diagnostics Sales Forecastby Market SegmentU.K.CMV Testing Market Diagnostics Salesby Major SupplierU.S.A.CMV Test Volume and Diagnostics Sales Forecastby Market SegmentU.S.A.CMV Testing Market Diagnostics Salesby Major SupplierContact: sales@reportsandreports.com for more information.